These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34155573)

  • 1. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
    Shenoy P; Ahmed S; Shanoj KC; Shenoy V; Damodaran D; Menon AR; Alias B; SanjoSaijan ; Devakumar D; Babu ASS
    Clin Rheumatol; 2021 Nov; 40(11):4665-4670. PubMed ID: 34155573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
    Pang R; Zhao J; Gan Z; Hu Z; Xue X; Wu Y; Qiao Q; Zhong A; Xia X; Liao H; Wang Z; Zhang L
    Aging (Albany NY); 2020 Dec; 12(23):23427-23435. PubMed ID: 33289698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
    Frommert LM; Arumahandi de Silva AN; Zernicke J; Scholz V; Braun T; Jeworowski LM; Schwarz T; Tober-Lau P; Ten Hagen A; Habermann E; Kurth F; Sander LE; Corman VM; Burmester GR; Biesen R; Albach FN; Klotsche J
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36597977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey.
    Misra R; Bhattacharya D; Ahmed S; Amin S; Shobha V; Ghosh A; Pandya SC; Parai D; Padhan P; Priyadarshini S; Mohapatra I; Patro ARK; Mohanty AP; Pati S
    Rheumatol Int; 2024 Jan; 44(1):81-87. PubMed ID: 37906254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.
    Lakota K; Perdan-Pirkmajer K; Sodin-Šemrl S; Čučnik S; Šubelj V; Prosenc K; Mrak Poljšak K; Tomšič M; Ambrožič A; Praprotnik S
    Clin Rheumatol; 2019 May; 38(5):1277-1292. PubMed ID: 30761436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case-Control Study from Astana, Kazakhstan.
    Rutskaya-Moroshan K; Abisheva S; Abisheva A; Amangeldiyeva Z; Vinnik T; Batyrkhan T
    Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336418
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan.
    Yamaguchi Y; Nameki S; Kato Y; Saita R; Sato T; Nagao S; Murakami T; Yoshimine Y; Amiya S; Morita T; Okita Y; Kawasaki T; Fujimoto J; Ueda Y; Maeda Y; Watanabe A; Takamatsu H; Nishida S; Shima Y; Narazaki M; Kumanogoh A
    Lancet Reg Health West Pac; 2023 Mar; 32():100661. PubMed ID: 36569794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
    Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
    Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and associated outcomes of COVID-19 infection among Ghanaian autoimmune rheumatic disease patients.
    Dey D; Katso B; Nyame D; Issaka S; Adjei P
    Ghana Med J; 2024 Sep; 58(3):184-191. PubMed ID: 39398093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.
    Van Doornum S; Bohensky M; Tacey MA; Brand CA; Sundararajan V; Wicks IP
    Arthritis Res Ther; 2015 Feb; 17(1):38. PubMed ID: 25879786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.
    Akkuzu G; Bes C; Özgür DS; Karaalioğlu B; Mutlu MY; Yıldırım F; Atagündüz P; Gündüz A; Soy M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2143-2151. PubMed ID: 36930514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evolution and levels of anti-S SARS-CoV-2 IgG in rheumatic disease and COVID-19].
    Medina GA; Pino M; Geffner J; Perrotta NA; Barrios CV
    Medicina (B Aires); 2021; 81(6):902-907. PubMed ID: 34875586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
    Arumahandi de Silva AN; Frommert LM; Albach FN; Klotsche J; Scholz V; Jeworowski LM; Schwarz T; Ten Hagen A; Zernicke J; Corman VM; Drosten C; Burmester GR; Biesen R
    Ann Rheum Dis; 2022 Jun; 81(6):881-888. PubMed ID: 35288376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
    Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of autoimmune rheumatic disease-related organizing pneumonia.
    Dong X; Zheng Y; Wang L; Chen WH; Zhang YG; Fu Q
    Clin Rheumatol; 2018 Apr; 37(4):1027-1035. PubMed ID: 28748510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.
    Boekel L; Hooijberg F; Vogelzang EH; Besten YR; Leeuw M; Atiqi S; van Vollenhoven RF; Wijbrandts CA; Gerritsen M; Krieckaert C; Dijkshoorn B; Bakhlakh S; Crooijmans JJ; Voskuyl A; van der Horst-Bruinsma IE; Lems W; Kuijpers TW; van Ham SM; Wieske L; Eftimov F; Kummer LY; van Dam PK; Stalman EW; Steenhuis M; Keijzer S; Cristianawati O; Keijser J; Loeff FC; Tas SW; Nurmohamed MT; Boers M; Rispens T; Wolbink G
    RMD Open; 2022 Apr; 8(1):. PubMed ID: 35383121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.
    Saxena A; Guttmann A; Masson M; Kim MY; Haberman RH; Castillo R; Scher JU; Deonaraine KK; Engel AJ; Belmont HM; Blazer AD; Buyon JP; Fernandez-Ruiz R; Izmirly PM;
    Lancet Rheumatol; 2021 Aug; 3(8):e585-e594. PubMed ID: 34075358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 outcomes in patients with and without autoimmune rheumatic diseases: A multicenter comparative study.
    Abdulnaby NK; Gamal SM; Alkemary A; Abdo M; Sabry IM; Belita MI; Mohamed SS
    Int J Rheum Dis; 2023 May; 26(5):870-877. PubMed ID: 36929695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study.
    Kim MS; Lee H; Lee SW; Kwon R; Rhee SY; Lee JA; Koyanagi A; Smith L; Fond G; Boyer L; Lee J; Rahmati M; Shin JY; Min C; Shin JI; Yon DK
    Ann Intern Med; 2024 Mar; 177(3):291-302. PubMed ID: 38437702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.